ImportRefusal LogoImportRefusal

Zydus Lifesciences Limited

⚠️ Moderate Risk

FEI: 3002984011 • Ahmedabad, Gujarat • INDIA

FEI

FEI Number

3002984011

📍

Location

Ahmedabad, Gujarat

🇮🇳

Country

INDIA
🏢

Address

Survey No. 417, 419 and 420, Sarkhej Bavla N. H. No. 8A Village-Moraiya, , Taluka Sanand, Ahmedabad, Gujarat, India

Moderate Risk

FDA Import Risk Assessment

47.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

10
Total Refusals
4
Unique Violations
11/17/2022
Latest Refusal
4/26/2007
Earliest Refusal

Score Breakdown

Violation Severity
76.4×40%
Refusal Volume
38.6×30%
Recency
22.8×20%
Frequency
6.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2232×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

Refusal History

DateProductViolationsDivision
11/17/2022
64RCE17ANASTROZOLE (HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/11/2020
64MCY04CHORIONIC GONADOTROPIN (GONAD-STIMULATING PRINCIPLE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/12/2016
63BDA35CLENBUTEROL (BRONCHODILATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/12/2016
64MDA04CHORIONIC GONADOTROPIN (GONAD-STIMULATING PRINCIPLE)
75UNAPPROVED
New Orleans District Office (NOL-DO)
7/27/2016
64MCK04CHORIONIC GONADOTROPIN (GONAD-STIMULATING PRINCIPLE)
75UNAPPROVED
New Orleans District Office (NOL-DO)
5/17/2016
64MDP04CHORIONIC GONADOTROPIN (GONAD-STIMULATING PRINCIPLE)
27DRUG GMPS
75UNAPPROVED
Cincinnati District Office (CIN-DO)
8/13/2014
62OCA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II)
223FALSE
Baltimore District Office (BLT-DO)
8/13/2014
62OCA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II)
223FALSE
Baltimore District Office (BLT-DO)
4/26/2007
61NIA76PAROXETINE (ANTI-DEPRESSANT)
118NOT LISTED
New Orleans District Office (NOL-DO)
4/26/2007
61NIA76PAROXETINE (ANTI-DEPRESSANT)
118NOT LISTED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Zydus Lifesciences Limited's FDA import refusal history?

Zydus Lifesciences Limited (FEI: 3002984011) has 10 FDA import refusal record(s) in our database, spanning from 4/26/2007 to 11/17/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Zydus Lifesciences Limited's FEI number is 3002984011.

What types of violations has Zydus Lifesciences Limited received?

Zydus Lifesciences Limited has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Zydus Lifesciences Limited come from?

All FDA import refusal data for Zydus Lifesciences Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.